Soeterik TFW, Van Melick HHE, Dijksman LM, et al. Dutch practice patterns of active surveillance for prostate cancer: Is there a relationship between protocol adherence and oncological outcomes? EMUC 2017, P042.
FDA keurt pembrolizumab goed voor adjuvante behandeling stadium IIB/IIC-melanoom
dec 2021 | Dermato-oncologie, Immuuntherapie